ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.


Associated Editors


The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.


Kurhausstraße 12
D-97688 Bad Kissingen
Germany
Telefon +49-971-6 4832
Fax +49- 971- 6 8637
Email asn@neurootology.org

 

Publications by

Dr. med. Francesco Mora

6 publications on the archives

Sodium enoxaparin and venovenous hemofiltration for treatment of sudden sensorineural hearing loss and tinnitus.

The pathogenesis of sudden sensorineural hearing loss (SNHL) and tinnitus are still not well understood. Prompted by such observations, we implemented a protocol using sodium enoxaparin associated with a venovenous hemofiltration for treatment of sudden hearing loss and tinnitus. The venovenous hemofiltration selectively eliminates fibrinogen, low-density lipoprotein, cholesterol, triglycerides, lipoprotein and complement from the blood […]


Sodium enoxaparin for treatment of immune-mediated sensorineural hearing loss (imsnhl)

The literature does not report others therapeutic protocols for immune-mediated sensorineural hearing loss (IMSNHL) treatment with sodium enoxaparin or other kinds of unfractionated heparin: our decision to use enoxaparin was based both on the pathogenesis of this condition and on evaluation of the other classes of drugs currently used. Fifty patients, who had suffered from […]


The use of enoxaparin for the treatment of tinnitus.

Microthrombotic vascular lesions could be the primary or secondary cause but, however, in most of the cases are at the base of the lesions of tinnitus. On those bases we consider that a therapy with enoxaparine has a wide field of action. Two hundred cases of patients, who had suffered from tinnitus for at least […]


The use of “rt-pa” for the treatment of sudden and “chronic hearing loss”

Eighty patients with sudden hearing loss and seventy patients with a chronical cochlear function decreasing have been treated until now with intravenous infusion of a recombinant glycoprotein analogous tissutal plasminogen activator (rt-PA): 3mg dissolved in 250mg of physiological saline given every 12 hr intravenously. Specifically excluded were patients with abnormal known coagulation. No patient was […]


Virtual reality and vestibular rehabilitation. six years of experience.

To test the application of virtual reality (VR) on our patients we used a particular “helmet” connected to a personal computer. The rehabilitation training is divided in two phases: “passive” and “active”. RV 752 patients, 259 males and 393 females, had been submitted to the vestibular rehabilitation with VR. The patients were affected with: Paroxysmal […]


The use of sodic enoxaparin in the treatment of tinnitus

Tinnitus is a pathological event caused by abnormal stimulation of any point along the acoustic pathway. Generally it has a sharp tone accompanied by hearing impairment. Currently no widely-used standard protocol for treatment of this condition exists and vascular microthrombotic factors are considered as the main determinants. Prompted by such observations, we implemented a protocol […]


Login

Registration

If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of

Authors

Archives

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |

(bi)gital»